INTEC PHARMA LTD JERUSALEM - SHS

Historical Holders from Q3 2015 to Q2 2021

Type / Class
Equity / SHS
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2021 Q2 0 $0 -$3,000 0
2021 Q1 890 $3,000 -$415,000 $3.37 1
2020 Q4 120,991 $418,000 -$8,342,002 $3.45 1
2020 Q3 4,422,402 $1,107,995 -$716,779 $0.25 21
2020 Q2 7,168,178 $2,029,120 +$383,888 $0.28 22
2020 Q1 5,898,340 $1,157,779 -$30,213 $0.20 17
2019 Q4 5,421,812 $2,702,978 -$510,765 $0.50 24
2019 Q3 5,700,731 $4,082,883 -$25,458,125 $0.73 33
2019 Q2 11,386,099 $49,381,346 +$308,773 $4.34 49
2019 Q1 11,043,172 $80,944,896 -$6,727,240 $7.33 39
2018 Q4 11,957,539 $90,132,346 -$7,504,039 $7.54 33
2018 Q3 13,019,261 $72,182,000 -$5,432,925 $5.65 26
2018 Q2 14,798,820 $65,556,000 +$18,732,893 $4.40 26
2018 Q1 10,534,093 $66,648,000 -$1,274,711 $6.32 23
2017 Q4 10,797,500 $55,607,000 -$14,089,683 $5.15 20
2017 Q3 10,470,510 $93,712,000 +$77,212,478 $8.95 16
2017 Q2 1,877,155 $10,700,000 +$170,592 $5.70 6
2017 Q1 1,847,550 $9,465,000 +$1,766,684 $5.11 5
2016 Q4 1,486,024 $8,469,000 -$3,199,432 $5.70 6
2016 Q3 2,026,123 $11,884,000 -$4,501,597 $5.88 7
2016 Q2 2,819,991 $12,896,000 +$1,709,335 $4.60 6
2016 Q1 2,467,552 $10,175,000 -$129,122 $4.13 7
2015 Q4 2,498,847 $13,394,000 -$417,986 $5.36 6
2015 Q3 2,574,523 $14,419,000 +$14,419,000 $5.60 8